These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 3622018)

  • 1. Nifedipine in pulmonary arterial hypertension. Importance of Raynaud's phenomenon.
    Fisher J; Mack RJ; Likier HM; Schiff AN; Borer JS
    Chest; 1987 Sep; 92(3):400-5. PubMed ID: 3622018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic effects of nifedipine on secondary pulmonary hypertension in man.
    Garzaniti N; el Allaf D; D'Orio V; Cremers S; Marcelle R; Carlier J
    Acta Cardiol; 1985; 40(2):207-15. PubMed ID: 3873156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nifedipine-induced fingertip vasodilation in patients with Raynaud's phenomenon.
    Creager MA; Pariser KM; Winston EM; Rasmussen HM; Miller KB; Coffman JD
    Am Heart J; 1984 Aug; 108(2):370-3. PubMed ID: 6380254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of nifedipine in hypertension and Raynaud's phenomenon.
    Kiowski W; Erne P; Bühler FR
    Cardiovasc Drugs Ther; 1990 Aug; 4 Suppl 5():935-40. PubMed ID: 2076403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of nitric oxide, nitroprusside, and nifedipine on hemodynamics and right ventricular contractility in patients with chronic pulmonary hypertension.
    Cockrill BA; Kacmarek RM; Fifer MA; Bigatello LM; Ginns LC; Zapol WM; Semigran MJ
    Chest; 2001 Jan; 119(1):128-36. PubMed ID: 11157594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic effects of nifedipine versus hydralazine in primary pulmonary hypertension.
    Fisher J; Borer JS; Moses JW; Goldberg HL; Niarchos AP; Whitman HH; Mermelstein M
    Am J Cardiol; 1984 Sep; 54(6):646-50. PubMed ID: 6475787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary vascular response during Raynaud's phenomenon in progressive systemic sclerosis.
    Shuck JW; Oetgen WJ; Tesar JT
    Am J Med; 1985 Feb; 78(2):221-7. PubMed ID: 3970048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nifedipine in primary Raynaud's phenomenon and in scleroderma: oral versus sublingual hemodynamic effects.
    Wollersheim H; Thien T; van 't Laar A
    J Clin Pharmacol; 1987 Nov; 27(11):907-13. PubMed ID: 3429697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The concept of Raynaud's phenomenon of the lung revisited.
    Lampert E; Charloux A; Lonsdorfer J; Frans A
    Am J Med; 1996 Nov; 101(5):468-71. PubMed ID: 8948269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study.
    Rademaker M; Cooke ED; Almond NE; Beacham JA; Smith RE; Mant TG; Kirby JD
    BMJ; 1989 Mar; 298(6673):561-4. PubMed ID: 2467711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute and long-term effects of nifedipine on pulmonary and systemic hemodynamics in patients with pulmonary hypertension associated with diffuse systemic sclerosis, the CREST syndrome and mixed connective tissue disease.
    Alpert MA; Pressly TA; Mukerji V; Lambert CR; Mukerji B; Panayiotou H; Sharp GC
    Am J Cardiol; 1991 Dec; 68(17):1687-91. PubMed ID: 1746473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syncope and Raynaud's disease.
    Guiloff RJ; Rajakulendran S; Angus-Leppan H
    Arch Neurol; 2012 May; 69(5):608-13. PubMed ID: 22248476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nifedipine therapy on pulmonary Raynaud's in primary Sjögren's syndrome.
    Joseph BZ; Organek HW; Grant A; Axelrod DA
    Clin Exp Rheumatol; 1988; 6(4):409-10. PubMed ID: 3229032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raynaud's phenomenon of the nipple: a treatable cause of painful breastfeeding.
    Anderson JE; Held N; Wright K
    Pediatrics; 2004 Apr; 113(4):e360-4. PubMed ID: 15060268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Action of nifedipine on the post-ischemic cold hyperemia reaction in Raynaud's phenomenon].
    Vayssairat M; Blaison N; Baudot N; Evenou P; Gilard M; Mathieu JF
    J Mal Vasc; 1989; 14(4):299-302. PubMed ID: 2584886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responses to nifedipine by patients with Raynaud's disease and Raynaud's phenomenon secondary to another disease.
    Riccio A; Del Puente A; Farinaro C; Scarpa R; Oriente P; Rocco P; Gioia M
    Clin Ther; 1987; 9(2):232-7. PubMed ID: 3568066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled double-blind trial of dazoxiben and nifedipine in the treatment of Raynaud's phenomenon.
    Ettinger WH; Wise RA; Schaffhauser D; Wigley FM
    Am J Med; 1984 Sep; 77(3):451-6. PubMed ID: 6540986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine.
    Coleiro B; Marshall SE; Denton CP; Howell K; Blann A; Welsh KI; Black CM
    Rheumatology (Oxford); 2001 Sep; 40(9):1038-43. PubMed ID: 11561116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term effects of sildenafil in a patient with scleroderma-associated pulmonary hypertension and Raynaud's syndrome].
    Rosenkranz S; Caglayan E; Diet F; Karasch T; Weihrauch J; Wassermann K; Erdmann E
    Dtsch Med Wochenschr; 2004 Aug; 129(33):1736-40. PubMed ID: 15295684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Raynaud's phenomenon with calcium channel blockers.
    Smith CR; Rodeheffer RJ
    Am J Med; 1985 Feb; 78(2B):39-42. PubMed ID: 3976694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.